SCHEMBL3801496

SCHEMBL3801496

O=C(O)[C@H](CO)NC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ PYGB P11216 7/20 0.51
▸ GAA P10253 1/20 0.51
▸ CA12 O43570 3/20 0.49
▸ CA1 P00915 3/20 0.49
▸ CA2 P00918 3/20 0.49
▸ CA9 Q16790 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27997210 1.00 PYGB (0.51) PYGBGAACA12CA1CA2
SCHEMBL20476841 1.00 PYGB (0.51) PYGBGAACA12CA1CA2
SCHEMBL2012475 1.00 PYGB (0.51) PYGBGAACA12CA1CA2
SCHEMBL867964 1.00 PYGB (0.51) PYGBGAACA12CA1CA2
SCHEMBL28419458 1.00 PYGB (0.51) PYGBGAACA12CA1CA2
SCHEMBL29550937 0.98 PYGB (0.49) PYGBGAACA12CA1CA2
SCHEMBL7048684 0.87 PYGB (0.49) PYGBGAACA12CA1CA2
SCHEMBL2848040 0.86 PYGB (0.44) PYGBGAACA12CA1CA2
SCHEMBL4006332 0.86 PYGB (0.44) PYGBGAACA12CA1CA2
SCHEMBL670576 0.86 PYGB (0.44) PYGBGAACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117070-A1 NEAR-INFRARED FLUORESCENT HEPTAMETHINE DYE CONJUGATES WITH FAVORABLE BLEACHING PROPERTIES HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2026-04-30 — — US disclosed
US-12583889-B2 Cell penetrating peptides OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2026-03-24 — — US disclosed
US-7803764-B2 Amphipathic glycopeptides THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2010-09-28 — — US disclosed
US-20080207492-A1 Amphipathic Glycopeptides THE ARIZONA BD OF REG ON BEHALF OF THE UNIV OF AZ (US) 2008-08-28 — — US disclosed
EP-1729790-A1 AMPHIPATHIC GLYCOPEPTIDES Polt, Robin (US) 2006-12-13 — — EP disclosed
WO-2005097158-A1 AMPHIPATHIC GLYCOPEPTIDES THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2005-10-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583889-B2 Cell penetrating peptides SLC2A3, SLC1A5, SLC2A1 PYGB 50/4885GAA 1852/4885CA12 2760/4885
US-20260117070-A1 NEAR-INFRARED FLUORESCENT HEPTAMETHINE DYE CONJUGATES WITH FAVORABLE BLEACHING PROPERTIES CBR1, CBR3, NR2E3 PYGB 4165/4885GAA 2621/4885CA12 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback